Literature DB >> 16865377

Outcome predictors in the management of spinal cord ependymoma.

D Gavin Quigley1, Naeem Farooqi, Timothy J D Pigott, Gordon F G Findlay, Robin Pillay, Neil Buxton, Michael D Jenkinson.   

Abstract

The aim of this study was to determine predictors of functional outcome and survival in a retrospective cohort of spinal cord ependymomas treated at a single institution. Twenty-six patients who underwent treatment of spinal cord ependymoma at a single institution were retrospectively analysed. The clinicopathological features were reviewed and correlated with functional outcome (measured using the Frankel grade), recurrence (clinical or radiological), progression-free survival (PFS) and overall survival (OS). Seventy-nine percent of patients with complete excision had maintained or improved functional outcome, compared to 75% in the incomplete resection plus radiotherapy group. Patients with a good pre-operative Frankel grade tended to maintain their functional status, though this did not reach statistical significance (Fisher's Exact test, P = 0.090). Univariate analysis revealed that longer symptom duration prior to treatment was associated with poorer functional outcome (P = 0.006). Extent of resection and the use of adjuvant radiotherapy did not influence PFS or OS; however, early diagnosis and treatment are paramount in the management of spinal ependymoma if a good functional outcome is to be achieved.

Entities:  

Mesh:

Year:  2006        PMID: 16865377      PMCID: PMC2200709          DOI: 10.1007/s00586-006-0168-y

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  21 in total

1.  Radiation tolerance of the spinal cord.

Authors:  W M Wara; T L Phillips; G E Sheline; J G Schwade
Journal:  Cancer       Date:  1975-06       Impact factor: 6.860

2.  Ependymoma: a follow-up study of 101 cases.

Authors:  S J Mork; A C Loken
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

3.  Radiotherapeutic management of adult intraspinal ependymomas.

Authors:  E G Shaw; R G Evans; B W Scheithauer; D M Ilstrup; J D Earle
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-03       Impact factor: 7.038

4.  Radiation myelopathy.

Authors:  J J Palmer
Journal:  Brain       Date:  1972       Impact factor: 13.501

5.  Spinal cord ependymoma: radical surgical resection and outcome.

Authors:  Fadi Hanbali; Daryl R Fourney; Eric Marmor; Dima Suki; Laurence D Rhines; Jeffrey S Weinberg; Ian E McCutcheon; Ian Suk; Ziya L Gokaslan
Journal:  Neurosurgery       Date:  2002-11       Impact factor: 4.654

6.  Spinal cord ependymomas.

Authors:  J Brotchi; G Fischer
Journal:  Neurosurg Focus       Date:  1998-05-15       Impact factor: 4.047

7.  Outcome after operative treatment of intramedullary spinal cord tumors in adults: intermediate and long-term results in 51 patients.

Authors:  P R Cooper
Journal:  Neurosurgery       Date:  1989-12       Impact factor: 4.654

8.  Spinal cord ependymomas: a retrospective analysis of 59 cases.

Authors:  J N Waldron; N J Laperriere; L Jaakkimainen; W J Simpson; D Payne; M Milosevic; C S Wong
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-09-30       Impact factor: 7.038

9.  Management of intramedullary spinal cord tumors.

Authors:  G Kopelson; R M Linggood; G M Kleinman; J Doucette; C C Wang
Journal:  Radiology       Date:  1980-05       Impact factor: 11.105

10.  Primary spinal cord tumors treated with surgery and postoperative irradiation.

Authors:  D M Garcia
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-11       Impact factor: 7.038

View more
  12 in total

Review 1.  A survey of the "medical" articles in the European Spine Journal, 2007.

Authors:  Michel Benoist
Journal:  Eur Spine J       Date:  2008-01-08       Impact factor: 3.134

Review 2.  A survey of the "surgical and research" articles in the European Spine Journal, 2007.

Authors:  Robert C Mulholland
Journal:  Eur Spine J       Date:  2008-01-08       Impact factor: 3.134

3.  Clinical features and long-term outcomes of intraspinal ependymomas in pediatric patients.

Authors:  Tao Yang; Liang Wu; Chenlong Yang; Xiaofeng Deng; Yulun Xu
Journal:  Childs Nerv Syst       Date:  2014-08-21       Impact factor: 1.475

4.  Diagnosis and rehabilitation of a pregnant woman with spinal cord disorder due to spinal cord tumor.

Authors:  Jason Bitterman; Jayne Donovan; Mylan Lam
Journal:  Spinal Cord Ser Cases       Date:  2019-01-24

5.  Myxopapillary ependymoma as a cause of back pain in a young male - A case report.

Authors:  Trung P Ngo; John Dufton; Paula J Stern; Omar Islam
Journal:  J Can Chiropr Assoc       Date:  2013-06

6.  Long-term outcomes of surgical resection with or without adjuvant radiation therapy for treatment of spinal ependymoma: a retrospective multicenter study by the Korea Spinal Oncology Research Group.

Authors:  Sun-Ho Lee; Chun Kee Chung; Chi Heon Kim; Sang Hoon Yoon; Seung-Jae Hyun; Ki-Jeong Kim; Eun-Sang Kim; Whan Eoh; Hyun-Jib Kim
Journal:  Neuro Oncol       Date:  2013-04-10       Impact factor: 12.300

7.  Treatment of spinal cord tumors.

Authors:  Brian Vaillant; Monica Loghin
Journal:  Curr Treat Options Neurol       Date:  2009-07       Impact factor: 3.598

8.  Comparative clinical study on seldom segment with multiple segment intramedullary primary spinal cord tumors.

Authors:  J J Sun; J Yang; J C Xie; Q Chang; C C Ma; M Zheng; H I Liao; T Wang; X D Chen; Y F Han; G Z Lin; T Yu; J Zhang; Y Si
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-10-18

9.  Multisegmental versus monosegmental intramedullary spinal cord ependymomas: perioperative neurological functions and surgical outcomes.

Authors:  Chenlong Yang; Jianjun Sun; Jingcheng Xie; Changcheng Ma; Bin Liu; Tao Wang; Xiaodong Chen; Jian Wu; Haibo Wu; Mei Zheng; Qing Chang; Jun Yang
Journal:  Neurosurg Rev       Date:  2021-05-14       Impact factor: 3.042

10.  Acute Paraplegia as a Result of Hemorrhagic Spinal Ependymoma Masked by Spinal Anesthesia: Case Report and Review of Literature.

Authors:  Sang-Hyo Lee; David Jaehyun Park; Sin-Soo Jeun
Journal:  Brain Tumor Res Treat       Date:  2016-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.